CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Restricted access Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease: The EXCEL Trial Autologous CD34+ Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular Dysfunction Outcomes of patients with and without baseline lipid-lowering therapy undergoing revascularization for left main coronary artery disease: analysis from the EXCEL trial Machine Learning Using CT-FFR Predicts Proximal Atherosclerotic Plaque Formation Associated With LAD Myocardial Bridging Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension C-reactive protein and prognosis after percutaneous coronary intervention and bypass graft surgery for left main coronary artery disease: Analysis from the EXCEL trial Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association Attenuated Mitral Leaflet Enlargement Contributes to Functional Mitral Regurgitation After Myocardial Infarction Parallel Murine and Human Plaque Proteomics Reveals Pathways of Plaque Rupture Angiographic derived endothelial shear stress: a new predictor of atherosclerotic disease progression

Consensus2019 Jan 15. [Epub ahead of print]

JOURNAL:EuroIntervention. Article Link

Percutaneous Recanalization of Chronic Total Occlusions: 2019 Consensus Document from the EuroCTO Club

Galassi AR, Werner GS, Boukhris M et al. Keywords: drug-eluting stent; stable angina; Chronic coronary total occlusion

ABSTRACT


Since its inception in December 2006, the EuroCTO Club has strived to provide the framework for state-of-the-art chronictotal occlusion (CTO) percutaneous coronary intervention (PCI) in Europe and nearby regions. Among its initiatives, the EuroCTO Club has published a set of recommendations regarding the technical aspects of CTO PCI, whose last edition dates to 2012. The EuroCTO Club consensus document discusses CTO PCI clinical indications, techniques and equipment use, as well as operators/centers qualifications. Given the considerable amount of progress made by this subspecialty during the last years, there is the need for an updated document that includes data from recent clinical trials and registries, information on novel devices and techniques, and an up-to-date revision on the training requirements to approach CTO PCI. The current updated consensus document of the EuroCTO club reflects the expertise of European operators to promote the widespread application of state-of-the-art CTO PCI not only in Europe but also across neighboring communities.